Pim‐2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma. (17th October 2016) - Teramachi, Jumpei; Hiasa, Masahiro; Oda, Asuka; Harada, Takeshi; Nakamura, Shingen; Amachi, Ryota; Tenshin, Hirofumi; Iwasa, Masami; Fujii, Shiro; Kagawa, Kumiko; Miki, Hirokazu; Kurahashi, Kiyoe; et al.